Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03868904 · ClinicalTrials.gov registry record
INSPIRE Continuation Post-Approval Study
A clinical trial of Bronchiolitis Obliterans, sponsored by TransMedics.
- Completed
- Registry status
- 220
- Enrollment target
- 17
- Study locations
NCT03868904 is a study of Bronchiolitis Obliterans that has completed, run by TransMedics. The registered enrollment target is 220 participants, below the 384-participant average among 9 other Bronchiolitis Obliterans trials with a reported enrollment target (43% lower). The trial reports 17 study locations across 9 states.
The verdict
NCT03868904, a study of Bronchiolitis Obliterans, has completed, sponsored by TransMedics.
- COMPLETED
- Registry status
- 220 participants
- Enrollment target
- 17
- Study locations
Study Summary
To evaluate long-term BOS-free survival outcomes of the OCS™ Lung INSPIRE Trial patients.
Conditions Studied
Interventions
- DEVICE OCS Lung System
Study Locations (17)
Other
- University of Leuven Hospital - Leuven
- N.H.C Hospital Civil - Strasbourg
- German Heart Institute Berlin - Berlin
- Hannover Medical School - Hanover
- University of Padua - Padua
- Hospital Universitario Puerta De Hierro - Madrid
- Papworth Hospital - Cambridge
- Harefield Hospital - Middlesex
California
- UCLA Medical Center - Los Angeles
- University of California at San Francisco - San Francisco
Arizona
- St. Joseph's Hospital and Medical Center - Phoenix
Indiana
- Indiana University - Indianapolis
Massachusetts
- Massachusetts General Hospital - Boston
Minnesota
- University of Minnesota - Minneapolis
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
New South Wales
- St. Vincent's Hospital - Darlinghurst
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2019-06-30 |
| Est. Completion | 2021-10-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03868904
The ClinicalTrials.gov registry entry for NCT03868904 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 384-participant average among 9 other Bronchiolitis Obliterans trials with a reported enrollment target (43% lower). The listed sponsor is TransMedics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bronchiolitis Obliterans appearing as the primary indexed condition, and to 1 intervention - of which OCS Lung System is the first listed.
NCT03868904 reports 17 study locations spanning 9 distinct geographic areas - top geographies include Other, California, Arizona.
Frequently Asked Questions
What is clinical trial NCT03868904 about?
NCT03868904 is a clinical study titled "INSPIRE Continuation Post-Approval Study". To evaluate long-term BOS-free survival outcomes of the OCS™ Lung INSPIRE Trial patients.
What is the current status of trial NCT03868904?
This trial is currently completed. The enrollment target is 220 participants. The study started on 2019-06-30. Estimated completion is 2021-10-12.
What conditions does trial NCT03868904 study?
This clinical trial studies the following conditions: Bronchiolitis Obliterans.
What interventions are being tested in trial NCT03868904?
The interventions under investigation include: OCS Lung System (DEVICE).
Who is sponsoring clinical trial NCT03868904?
This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03868904 being conducted?
This trial has 17 study locations across Arizona, California, Indiana, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchiolitis Obliterans
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
RECRUITING
-
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RECRUITING · Phase 2
-
Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome
RECRUITING
-
Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)
ACTIVE NOT RECRUITING · Phase 3
-
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)
COMPLETED · Phase 3
-
Hp129 Xenon Imaging and BOS in Lung Transplantation
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.